| Variables | Mean ± SD; Median (min-maks) | Patients (n = 162), % |
| Age (years) | 59.11 ± 6.66; 59 (40 - 76) |
|
| Gender |
|
|
| Male |
| 135 (83.3%) |
| Female |
| 27 (16.7%) |
| History of Myocardial Infarction |
| 75 (46.3%) |
| CAD Risk Factors |
|
|
| DM |
| 74 (45.7%) |
| Hypertension |
| 113 (69.8%) |
| Dyslipidemia |
| 75 (46.3%) |
| Family History |
| 8 (4.9%) |
| Smoking |
| 87 (53.7%) |
| Menopause |
| 22 (81%) |
| Number of CAD Risk Factors ≥ 3 |
| 74 (45.6%) |
| BMI | 24.83 ± 3.78; 24 (16 - 44) |
|
| Underweight |
| 3 (1.9%) |
| Normal |
| 37 (22.8%) |
| Overweight |
| 51 (31.5%) |
| Obesitas |
| 71 (43.8%) |
| Ischemic ECG |
| 117 (72.2%) |
| Serum Creatinine (mg/dl) | 1.3 ± 0.32; 1.3 (0.75 - 3) |
|
| Creatinine ≥ 1.5 |
| 50 (30.8%) |
| Creatinine < 1.5 |
| 112 (69.1%) |
| Ejection Fraction (%) | 48.12 ± 14.63; 49 (14 - 78) |
|
| EF ≤ 45% |
| 59 (36.4%) |
| EF > 45% |
| 103 (63.5%) |
| CAD |
|
|
| CAD 2VD |
| 6 (3.7%) |
| CAD 3VD |
| 156 (96.3%) |
| LM Disease |
| 77 (47.5%) |
| CTO |
| 83 (51%) |
| LAD |
| 15 (9.2%) |
| RCA |
| 19 (11.7%) |
| LCx |
| 6 (3.7%) |
| LAD and RCA |
| 22 (13.5%) |
| LAD and LCx |
| 5 (3%) |
| RCA and LCx |
| 9 (5.5%) |
| LAD, RCA, LCx |
| 6 (3.7%) |
| LM |
| 1 (0.6%) |
| Syntax Score | 30.24 ± 3.66; 30 (24 - 39) |
|
| Medications |
|
|
| Antiplatelet |
| 162 (100%) |
| Beta-blocker |
| 140 (86.4%) |
| Digoxin |
| 7 (4.3%) |
| ACEi/ARB |
| 136 (84%) |
| Nitrate |
| 150 (92.6%) |
| Diuretics |
| 54 (33.3%) |
| MRA |
| 79 (48.8%) |
| Statin |
| 158 (97.5%) |
| CCB |
| 33 (20.4%) |
| Waiting time (Month) | 9.8 ± 6.02; 8.0 (1 - 31) |
|